BARCLAYS PLC - NIVALIS THERAPEUTICS INC ownership

NIVALIS THERAPEUTICS INC's ticker is NVLS and the CUSIP is 65481J109. A total of 28 filers reported holding NIVALIS THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of NIVALIS THERAPEUTICS INC
ValueSharesWeighting
Q2 2017$6,000
-33.3%
2,700
-32.5%
0.00%
Q4 2016$9,000
-72.7%
4,0000.0%0.00%
Q3 2016$33,000
+83.3%
4,000
-2.4%
0.00%
Q2 2016$18,000
+12.5%
4,097
+2.4%
0.00%
Q1 2016$16,000
-42.9%
4,0000.0%0.00%
Q4 2015$28,000
-41.7%
4,0000.0%0.00%
Q3 2015$48,0004,0000.00%
Other shareholders
NIVALIS THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Lamond Capital Partners LLC 225,000$3,409,0003.46%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,732,412$56,546,0001.88%
RA Capital Management 757,263$11,473,0001.15%
Rock Springs Capital Management LP 564,358$8,550,0000.62%
Monashee Investment Management LLC 62,500$947,0000.45%
SPHERA FUNDS MANAGEMENT LTD. 255,000$3,863,0000.38%
WALL STREET ASSOCIATES 192,400$2,915,0000.28%
Ghost Tree Capital, LLC 50,000$758,0000.25%
SABBY MANAGEMENT, LLC 430,041$6,515,0000.24%
Endurant Capital Management LP 46,500$704,0000.21%
View complete list of NIVALIS THERAPEUTICS INC shareholders